p18Ink4c and p53 act as tumor suppressors in Cyclin D1-driven primitive neuroectodermal tumor

Cancer Research

Volumn 69, Issue 2, 2009, Pages 440-448

  Saab, Raya ^a   Rodriguez Galindo, Carlos ^b   Matmati, Kelly ^b   Rehg, Jerold E ^b   Baumer, Shannon H ^c   Khoury, Joseph D ^b   Billups, Catherine ^b   Neale, Geoffrey ^b   Helton, Kathleen J ^b   Skapek, Stephen X ^c  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2C; PROTEIN P53; RETINOBLASTOMA PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EYE PROTEIN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; INTERSTITIAL RETINOL-BINDING PROTEIN; RETINOL BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE DISRUPTION; GENE INACTIVATION; GENE MUTATION; HETEROCHROMATIN; HISTOPATHOLOGY; MEDULLOBLASTOMA; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; PINEAL BODY; PINEAL BODY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; BRAIN TUMOR; C57BL MOUSE; CELL GROWTH; DISEASE COURSE; GENETICS; HUMAN; HYPERPLASIA; INFANT; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PRESCHOOL CHILD; PROTO ONCOGENE; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CHILD, PRESCHOOL; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; EYE PROTEINS; GENES, BCL-1; GENES, P53; HUMANS; HYPERPLASIA; INFANT; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROECTODERMAL TUMORS, PRIMITIVE; PHOSPHORYLATION; PINEAL GLAND; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; RETINOL-BINDING PROTEINS;

EID: 58349101329     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1892     Document Type: Article

References (47)

1. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005;24:2796-809.
2. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther 2002;1:226-31.
3. Arnold A, Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 2005;23:4215-24.
4. Lovec H, Grzeschiczek A, Kowalski M-B, Moroy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma. EMBO J 1994;13:3487-95.
5. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994;13:2124-30.
6. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994;369:669-71.
7. Deane NG, Parker MA, Aramadla R, et al. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res 2001;61:5389-95.
8. Becker LE, Hinton D. Primitive neuroectodermal tumors of the central nervous system. Hum Pathol 1983;14:538-50.
9. Neben K, Korshunov A, Benner A, et al. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res 2004;64:3103-11.
10. Gilbertson RJ. Medulloblastoma: signaling a change in treatment. Lancet Oncol 2004;5:209-18.
11. Oliver TG, Grasfeder LL, Carrol AL, et al. Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci U S A 2003;100:7331-6.
12. Pogoriler J, Millen K, Utset M, Du W. Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation. Development 2006;133:3929-37.
13. Liou GI, Geng L, Al-Ubaidi MR, et al. Tissue-specific expression in transgenic mice directed by the 5′-flanking sequences of the human gene encoding interphotoreceptor retinoid-binding protein. J Biol Chem 1990;265:8373-6.
14. Skapek SX, Lin S-CJ, Jablonski MM, et al. Persistent expression of cyclin D1 disrupts normal photoreceptor differentiation and retina development. Oncogene 2001;20:6742-51.
15. Silva RL, Thornton JD, Martin AC, et al. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye. EMBOJ 2005;24:2803-14.
16. Latres E, Malumbres M, Sotillo R, et al. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBOJ 2000;19:3496-506.
17. Chan PKS, Chan DPC, To K-F, Cheung JLK, Cheng AF. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol 2001;54:401-3.
18. Fung K-M, Trojanowski JQ. Animal models of medulloblastomas and related primitive neuroectodermal tumor. A review. J Neuropathol Exp Neurol 1995;54:285-96.
19. McKeller RN, Fowler JL, Cunningham JJ, et al. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proc Natl Acad Sci U S A 2002;99:3848-53.
20. Sumida M, Barkovich AJ, Newton TH. Development of the pineal gland: measurement with MR. AJNR Am J Neuroradiol 1996;17:233-6.
21. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992;70:993-1006.
22. 1-phase progression. Genes Dev 1999;13:1501-12.
23. Kitagawa M, Higashi H, Jung HK, et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBOJ 1996;15:7060-9.
24. Connell-Crowley L, Harper JW, Goodrich DW. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 1997;8:287-301.
25. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 2001;11:S27-31.
26. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004;2004:2919-33.
27. Mooi WJ, Peeper DS. Oncogene-induced cell senescence - halting on the road to cancer. N Engl J Med 2006;355:1037-46.
28. Narita M, Nunez S, Heard E, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003;113:703-16.
29. Ferbeyre G, de SE, Lin AW, et al. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol 2002;22:3497-508.
30. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602.
31. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-21.
32. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 1994;7:480-4.
33. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005;120:513-22.
34. -/- mice. Cell Cycle 2005;4:1316-9.
35. Uziel T, Zindy F, Xie S, et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev 2005;19:2656-67.
36. Blach LE, McCormick B, Abramson DH, Ellsworth RM. Trilateral retinoblastoma - incidence and outcome: a decade of experience. Int J Radiat Oncol Biol Phys 1994;29:729-33.
37. Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 1999;17:1829-37.
38. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Brennan MF, Levine AJ. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994;54:794-9.
39. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001;1:233-40.
40. Ramsey MR, Krishnamurthy J, Pei X-H, et al. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Cancer Res 2007;67:4732-41.
41. Zindy F, Nilsson LM, Nguyen L, et al. Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice. Cancer Res 2003;63:5420-7.
42. Zindy F, Uziel T, Ayrault O, et al. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors. Cancer Res 2007;67:2676-84.
43. Solomon DA, Kim J-S, Jenkins S, et al. Identification of p18INK4c as a tumor suppressor gene in glioblastoma multiforme. Cancer Res 2008;68:2564-9.
44. Sherr CJ. Principles of tumor suppression. Cell 2004;116:235-46.
45. Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T. p19Arf is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. Mol Cell Biol 2002;22:370-7.
46. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008;319:1352-5.
47. 1 cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol 2000;20:9055-67.